Interim guidance for the evaluation and management of infants with possible congenital Zika Virus Infection

Update: Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection — United States, August 2016

Centers for Disease Control and Prevention 2016

This guidance aims to assist US health care providers in the evaluation and management of infants with congenital Zika virus infection based on currently available data on congenital infections with Zika virus and other pathogens. The content includes ‘the Initial Laboratory Testing and Evaluation of Infants with Possible Congenital Zika Virus Infection’, ‘Outpatient Management of Infants with Laboratory Evidence of Zika Virus Infection and Abnormalities Consistent with Congenital Zika Syndrome’ and ‘Outpatient Management of Infants with Laboratory Evidence of Zika Virus Infection but Without Abnormalities Consistent with Congenital Zika Syndrome’.

If you have found this summary helpful, please consider making a donation. If everyone who looked at our COVID-19 resources gave us just £2 per month, it would fund Evidence Aid’s life-saving work.